Antigen Express Inc. - biopharmaceutical company developing novel immunotherapy products -

nav

Antigen Express is a platform and product-based company developing proprietary vaccine formulations for large, unmet medical needs.


8/7/2008	Enrollment of breast and ovarian cancer patients commenced for combination therapy trial to include Generex Biotechnology’s novel immunotherapeutic vaccine

7/9/2008	Investigational New Drug Application Submitted On Behalf of Generex Biotechnology for Combination Immunotherapy Vaccine Trials

6/26/2008	Generex Biotechnology Expands Mayo Clinic Collaboration for Vaccine Studies